<?xml version='1.0' encoding='utf-8'?>
<document id="31141832"><sentence text="A simple, rapid and fully validated HPLC method for simultaneous quantitative bio-analysis of rosuvastatin and candesartan in rat plasma: Application to pharmacokinetic interaction study."><entity charOffset="94-106" id="DDI-PubMed.31141832.s1.e0" text="rosuvastatin" /><entity charOffset="111-122" id="DDI-PubMed.31141832.s1.e1" text="candesartan" /><pair ddi="false" e1="DDI-PubMed.31141832.s1.e0" e2="DDI-PubMed.31141832.s1.e0" /><pair ddi="false" e1="DDI-PubMed.31141832.s1.e0" e2="DDI-PubMed.31141832.s1.e1" /></sentence><sentence text="A simple, precise and accurate HPLC method was developed, optimized and validated for simultaneous determination of rosuvastatin and candesartan in rat plasma using atorvastatin as an internal standard"><entity charOffset="116-128" id="DDI-PubMed.31141832.s2.e0" text="rosuvastatin" /><entity charOffset="133-144" id="DDI-PubMed.31141832.s2.e1" text="candesartan" /><entity charOffset="165-177" id="DDI-PubMed.31141832.s2.e2" text="atorvastatin" /><pair ddi="false" e1="DDI-PubMed.31141832.s2.e0" e2="DDI-PubMed.31141832.s2.e0" /><pair ddi="false" e1="DDI-PubMed.31141832.s2.e0" e2="DDI-PubMed.31141832.s2.e1" /><pair ddi="false" e1="DDI-PubMed.31141832.s2.e0" e2="DDI-PubMed.31141832.s2.e2" /><pair ddi="false" e1="DDI-PubMed.31141832.s2.e1" e2="DDI-PubMed.31141832.s2.e1" /><pair ddi="false" e1="DDI-PubMed.31141832.s2.e1" e2="DDI-PubMed.31141832.s2.e2" /></sentence><sentence text=" Solid-phase extraction was used for sample cleanup and its subsequent optimization was carried out to achieve higher extraction efficiency and to eliminate matrix effect" /><sentence text=" A quality by design approach was used, wherein three-level factorial design was applied for optimization of mobile phase composition and for assessing the effect of pH of the mobile phase using Design Expert Software" /><sentence text=" Adequate separation for both analytes was achieved with a Waters C18 column (250 × 4" /><sentence text="6 mm, 5 μm) using acetonitrile-5 mm sodium acetate buffer (70:30, v/v; pH adjusted to 3"><entity charOffset="18-50" id="DDI-PubMed.31141832.s6.e0" text="acetonitrile-5 mm sodium acetate" /></sentence><sentence text="5 with acetic acid) as a mobile phase at a flow rate of 1"><entity charOffset="7-18" id="DDI-PubMed.31141832.s7.e0" text="acetic acid" /></sentence><sentence text="0 mL/min and wavelength of 254 nm" /><sentence text=" The calibration curves were linear over the concentration ranges 5-150 and 10-300 ng/mL for rosuvastatin (ROS) and candesartan (CAN), respectively"><entity charOffset="93-105" id="DDI-PubMed.31141832.s9.e0" text="rosuvastatin" /><entity charOffset="116-127" id="DDI-PubMed.31141832.s9.e1" text="candesartan" /><entity charOffset="129-132" id="DDI-PubMed.31141832.s9.e2" text="CAN" /><pair ddi="false" e1="DDI-PubMed.31141832.s9.e0" e2="DDI-PubMed.31141832.s9.e0" /><pair ddi="false" e1="DDI-PubMed.31141832.s9.e0" e2="DDI-PubMed.31141832.s9.e1" /><pair ddi="false" e1="DDI-PubMed.31141832.s9.e0" e2="DDI-PubMed.31141832.s9.e2" /><pair ddi="false" e1="DDI-PubMed.31141832.s9.e1" e2="DDI-PubMed.31141832.s9.e1" /><pair ddi="false" e1="DDI-PubMed.31141832.s9.e1" e2="DDI-PubMed.31141832.s9.e2" /></sentence><sentence text=" The validated method was successfully applied to a pharmacokinetic study in Wistar rats and the data did not reveal any evidence for a potential drug-drug interaction between ROS and CAN"><entity charOffset="184-186" id="DDI-PubMed.31141832.s10.e0" text="CAN" /></sentence><sentence text=" This information provides evidence for clinical rational use of ROS and CAN"><entity charOffset="73-75" id="DDI-PubMed.31141832.s11.e0" text="CAN" /></sentence><sentence text="" /></document>